Accure Medical is developing BiaCure, a medical device that uses patented BiaPulse high‑frequency energy to eradicate onychomycosis infections while protecting surrounding tissue. The system features a reusable energy source that can treat two toes simultaneously and custom‑manufactured applicators created from ultrasound scans and a proprietary AI algorithm to match each patient’s nail geometry. This approach aims to provide a safer, more effective alternative to existing topical, oral, and device treatments.
Funding
$100K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Onychomycosis affects over 35 million people in the United States, causing disfiguring, painful nail infections that increase the risk of additional foot complications, especially in diabetic patients. Existing topical agents achieve cure rates of only 5–17 %, while oral antifungals carry significant systemic side effects and require extensive monitoring. No current therapy reliably eradicates the fungus within the nail plate and bed without compromising safety.
Solution
BiaCure’s BiaPulse™ system delivers high‑frequency energy (HFE) directly to the infected nail plate and underlying nail bed, destroying the fungal pathogen while sparing surrounding tissue. Each treatment uses a physician‑scanned ultrasound of the toe to generate a custom‑fit applicator that conforms to the nail’s size, thickness, and topography, ensuring precise energy coupling. A proprietary AI algorithm converts the scan data into a 3‑D printable applicator file, enabling rapid, patient‑specific manufacturing. The device treats two toes simultaneously and incorporates real‑time temperature monitoring to keep the treated digit within safe limits throughout the procedure. Data from each session are logged for clinical documentation and can be integrated into existing practice workflows.
Target Audience
Primary customers are podiatrists, dermatologists, and foot‑care clinics that treat onychomycosis, particularly those serving diabetic or high‑risk patient populations.
Features
- Reusable HFE energy source capable of concurrent treatment of two toes, improving clinic efficiency
- Custom applicators manufactured from ultrasound scans, tailored to each digit’s nail dimensions and disease extent
- Proprietary AI algorithm that transforms scan data into 3‑D printable files for on‑demand applicator production
- Integrated temperature control system that continuously monitors toe temperature and enforces safety thresholds
- Precise, localized energy delivery that targets the nail plate and bed while minimizing exposure to surrounding tissue
- Compliance with FDA labeling requirements for medical device safety and performance